个人中心 - 老虎社区

yooniique

IP属地：未知

帖子 · 45帖子 · 45
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- yooniiqueyooniique
  ·2021-06-19
  🤔🤔🤔
  Toy companies are keeping an eye on China shipping delays as key holiday season nears
  There may be fewer boxes under the tree this holiday season, as toymakers grapple with thepossibilit
  Toy companies are keeping an eye on China shipping delays as key holiday season nears
  1,344 1
  2
  分享
  举报
- yooniiqueyooniique
  ·2021-06-15
  👍🏻👍🏻👍🏻
  非常抱歉，此主贴已删除
  1,033 1
  1
  分享
  举报
- yooniiqueyooniique
  ·2021-06-14
  👍🏻👍🏻
  Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
  Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.
  Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
  1,059 评论
  点赞
  分享
  举报
- yooniiqueyooniique
  ·2021-06-13
  🤔🤔
  非常抱歉，此主贴已删除
  1,658 评论
  2
  分享
  举报
- yooniiqueyooniique
  ·2021-06-12
  🤔🤔🤔
  Investor, Trader, Speculator: Which One Are You?
  Understanding the difference between speculation and investing is essential to avoiding reckless ris
  Investor, Trader, Speculator: Which One Are You?
  1,017 评论
  1
  分享
  举报
- yooniiqueyooniique
  ·2021-06-11
  😱😱😱
  非常抱歉，此主贴已删除
  2,117 评论
  1
  分享
  举报
- yooniiqueyooniique
  ·2021-06-10
  👏🏻👏🏻👏🏻
  7 Movie Stocks Ready for the #AMCArmy’s Finale
  These seven stocks are looking to rebound this summer as people return to seeing films in theaters.
  7 Movie Stocks Ready for the #AMCArmy’s Finale
  1,258 3
  5
  分享
  举报
- yooniiqueyooniique
  ·2021-06-08
  😱😱
  Oil falls again amid concerns over demand rebound
  TOKYO, June 8 (Reuters) - Oil prices lost more ground on Tuesday as concerns about the fragile state
  Oil falls again amid concerns over demand rebound
  1,198 1
  1
  分享
  举报
- yooniiqueyooniique
  ·2021-06-07
  👍🏻👍🏻👍🏻
  非常抱歉，此主贴已删除
  1,011 评论
  点赞
  分享
  举报
- yooniiqueyooniique
  ·2021-06-06
  🤔🤔🤔
  非常抱歉，此主贴已删除
  1,258 2
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3582101588853029","uuid":"3582101588853029","gmtCreate":1619007700817,"gmtModify":1619014378177,"name":"yooniique","pinyin":"yooniique","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":135,"tweetSize":45,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":162125771,"gmtCreate":1624046361393,"gmtModify":1631889801990,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/162125771","repostId":"1197466929","repostType":4,"repost":{"id":"1197466929","kind":"news","pubTimestamp":1624028051,"share":"https://ttm.financial/m/news/1197466929?lang=&edition=full","pubTime":"2021-06-18 22:54","market":"us","language":"en","title":"Toy companies are keeping an eye on China shipping delays as key holiday season nears","url":"https://stock-news.laohu8.com/highlight/detail?id=1197466929","media":"cnbc","summary":"There may be fewer boxes under the tree this holiday season, as toymakers grapple with thepossibilit","content":"<div>\n<p>There may be fewer boxes under the tree this holiday season, as toymakers grapple with thepossibility of a massive shortagein everything from dolls and action figures to vehicles and puzzles.\nThe ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/hasbro-mattel-monitor-china-shipping-delays-as-holiday-season-nears.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toy companies are keeping an eye on China shipping delays as key holiday season nears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToy companies are keeping an eye on China shipping delays as key holiday season nears\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 22:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/18/hasbro-mattel-monitor-china-shipping-delays-as-holiday-season-nears.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There may be fewer boxes under the tree this holiday season, as toymakers grapple with thepossibility of a massive shortagein everything from dolls and action figures to vehicles and puzzles.\nThe ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/18/hasbro-mattel-monitor-china-shipping-delays-as-holiday-season-nears.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HAS":"孩之宝","MAT":"美国美泰公司"},"source_url":"https://www.cnbc.com/2021/06/18/hasbro-mattel-monitor-china-shipping-delays-as-holiday-season-nears.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1197466929","content_text":"There may be fewer boxes under the tree this holiday season, as toymakers grapple with thepossibility of a massive shortagein everything from dolls and action figures to vehicles and puzzles.\nThe pandemic created a bottleneck in the global transportation pipeline, which was later worsened by theblockage of the Suez Canal in March.These shipping delays have hit almost every industry, including electronics, apparel and food.\nExacerbating these troubles is afresh wave of coronavirus outbreaks in China.All the while, inventory continues to pile-up, leading to manufacturing delays. With shipping containers scarce — or worse, more than double pre-pandemic prices — toymakers are faced with tough decisions ahead of the industry's most important sales season.\n\"We're not seeing any panic yet about the flow of holiday goods,\" said Jefferies analyst Stephanie Wissink.\nWissink noted that toy companies are just entering the ramp-up period of production for toys that ship in September and October for the holidays.\n\"If we see persistent constraints into late-summer, then we will start to worry a bit more,\" she said.\nCurrently, the industry is seeing delays of two-to-three weeks, Wissink said. This is consistent with a report from Davidson analyst Linda Bolton Weiser that was published Friday, although Weiser said delays could be as long as a month.\nWeiser told CNBC that the toy industry has faced shipping challenges in the past and persevered. She noted that several years ago, there was a workers strike at the Port of Los Angeles that threatened holiday sales.\n\"Toy stocks tanked, but [Christmas] went off without a hitch,\" she said. \"Toy companies were able to get their toys loaded on the tops of freighters and unloaded the fastest.\"\nWeiser said her most recent chat with Mattel a few days ago indicated that the company was \"still quite confident about their sales growth for the year.\"\nRepresentatives forHasbroandMatteldid not immediately respond to CNBC's request for comment.\nToy companies are keeping a careful eye on developments overseas, hoping that pressure on the ports will loosen as vaccinations are more widely distributed globally, outbreaks are more isolated and more air traffic routes reopen.\nFor now, toy companies have not passed on additional shipping costs to the customer, Wissink said. However, there is always a possibility that this could change if the shipping situation does not alleviate.\n\"We note that holiday purchases are very much oriented toward gifting so price sensitivity is somewhat less,\" she said. \"That said, consumers will notice if there's a dramatic increase in prices, but we don't expect that at this stage.\"\nBoth Mattel and Habro shares were recently trading down more than 1% on Friday. Mattel's stock has gained nearly 9% since January, putting its market value at $6.64 billion. Hasbro's stock is down 3% year to date, which puts its market value at $12.5 billion.","news_type":1,"symbols_score_info":{"HAS":0.9,"MAT":0.9}},"isVote":1,"tweetType":1,"viewCount":1344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160394930,"gmtCreate":1623771536620,"gmtModify":1631889801993,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"&nbsp;👍🏻👍🏻👍🏻","listText":"&nbsp;👍🏻👍🏻👍🏻","text":"👍🏻👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160394930","repostId":"1127088935","repostType":4,"isVote":1,"tweetType":1,"viewCount":1033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185721863,"gmtCreate":1623674554752,"gmtModify":1631889801997,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"👍🏻👍🏻","listText":"👍🏻👍🏻","text":"👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/185721863","repostId":"2143578268","repostType":4,"repost":{"id":"2143578268","kind":"news","pubTimestamp":1623668820,"share":"https://ttm.financial/m/news/2143578268?lang=&edition=full","pubTime":"2021-06-14 19:07","market":"us","language":"en","title":"Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland","url":"https://stock-news.laohu8.com/highlight/detail?id=2143578268","media":"StreetInsider","summary":"Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.\n","content":"<p><i>Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.</i></p>\n<p>CAMBRIDGE, Mass.--(BUSINESS WIRE)--</p>\n<p><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>, (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted an authorization application to Swissmedic for use of its COVID-19 vaccine in adolescents.</p>\n<p>“We are pleased to announce that we have submitted an authorization application for our COVID-19 vaccine with Swissmedic for use in adolescents in Switzerland,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents. We have already filed for authorization with the U.S. FDA, Health Canada and the European Medicines Agency and we will continue to file with regulatory agencies around the world for this important younger age population. We remain focused on helping to end the COVID-19 pandemic.”</p>\n<p>In May, the Company announced that the Phase 2/3 TeenCOVE study of Moderna’s COVID-19 vaccine in adolescents met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of COVID-19 were observed in participants who had received two doses of the Moderna COVID-19 vaccine using the primary definition. The vaccine efficacy in the nearly 2,500 adolescents who received the Moderna COVID-19 vaccine was observed to be 100% when using the same case definition as in the Phase 3 COVE study in adults. In addition, a vaccine efficacy of 93% in seronegative participants was observed starting 14 days after the first dose using the secondary Centers for Disease Control and Prevention (CDC) case definition of COVID-19, which tested for milder disease. The study enrolled 3,732 participants ages 12 to less than 18 years in the U.S.</p>\n<p>The Moderna COVID-19 vaccine was generally well tolerated with a safety and tolerability profile generally consistent with the Phase 3 COVE study in adults. No significant safety concerns have been identified to date. The majority of adverse events were mild or moderate in severity. The most common solicited local adverse event was injection site pain. The most common solicited systemic adverse events after the second dose of mRNA-1273 were headache, fatigue, myalgia and chills. Safety data continues to accrue, and the study continues to be monitored by an independent safety monitoring committee. All participants will be monitored for 12 months after their second injection to assess long-term protection and safety. These data are subject to change based on ongoing data collection.</p>\n<p><b>About the Moderna COVID-19 Vaccine </b></p>\n<p>The Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the National Institutes of Health (NIH) on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of the Moderna COVID-19 Vaccine was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the U.S Food and Drug Administration granted the Moderna COVID-19 Vaccine Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of the vaccine. On July 8, the Phase 2 study completed enrolment.</p>\n<p>Results from the second interim analysis of the NIH-led Phase 1 study of the Moderna COVID-19 Vaccine in the 56-70 and 71+ age groups were published on September 29 in <i>The New England Journal of Medicine</i>. On November 30, 2020, Moderna announced the primary efficacy analysis of the Phase 3 study of the vaccine conducted on 196 cases. On November 30, 2020, the Company also announced that it filed for Emergency Use Authorization with the U.S. FDA and a Conditional Marketing Authorization (CMA) application with the European Medicines Agency. On December 18, 2020, the U.S. FDA authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age or older. Moderna has received emergency (or other conditional, interim or provisional) authorization for use of its COVID-19 vaccine in adults from health agencies in Canada, Israel, the European Union, the United Kingdom, Switzerland, Singapore, Qatar, Taiwan, the Philippines, Thailand, Brunei, Paraguay, Japan, South Korea, Botswana and an Emergency Use Listing (EUL) from the World Health Organization (WHO).</p>\n<p>Initial data from Moderna’s Phase 2 study in the U.S. showed that a single 50 µg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351 (first identified in South Africa) and P.1 (first identified in Brazil). A booster dose of mRNA-1273.351, the Company’s strain-matched booster, achieved higher neutralizing antibody titers against the B.1.351 variant of concern than a booster dose of mRNA-1273. Safety and tolerability profiles following third dose booster injections of 50 µg of mRNA-1273 or mRNA-1273.351 were generally comparable to those observed after the second dose of mRNA-1273 in the previously reported Phase 2 and Phase 3 studies. A manuscript describing these preliminary results was submitted as a preprint to <i>medRxiv</i> and will be submitted for peer-reviewed publication upon completion of the multivalent mRNA-1273.211 booster arm.</p>\n<p><b>About Moderna</b></p>\n<p>In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of <a href=\"https://laohu8.com/S/AONE\">one</a> of the earliest and most-effective vaccines against the COVID-19 pandemic.</p>\n<p>Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 14 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by <i>Science</i> for the past six years. To learn more, visit www.modernatx.com.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 19:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18553969><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.\nCAMBRIDGE, Mass.--(BUSINESS WIRE)--\nModerna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18553969\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18553969","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143578268","content_text":"Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.\nCAMBRIDGE, Mass.--(BUSINESS WIRE)--\nModerna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted an authorization application to Swissmedic for use of its COVID-19 vaccine in adolescents.\n“We are pleased to announce that we have submitted an authorization application for our COVID-19 vaccine with Swissmedic for use in adolescents in Switzerland,” said Stéphane Bancel, Chief Executive Officer of Moderna. “We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents. We have already filed for authorization with the U.S. FDA, Health Canada and the European Medicines Agency and we will continue to file with regulatory agencies around the world for this important younger age population. We remain focused on helping to end the COVID-19 pandemic.”\nIn May, the Company announced that the Phase 2/3 TeenCOVE study of Moderna’s COVID-19 vaccine in adolescents met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of COVID-19 were observed in participants who had received two doses of the Moderna COVID-19 vaccine using the primary definition. The vaccine efficacy in the nearly 2,500 adolescents who received the Moderna COVID-19 vaccine was observed to be 100% when using the same case definition as in the Phase 3 COVE study in adults. In addition, a vaccine efficacy of 93% in seronegative participants was observed starting 14 days after the first dose using the secondary Centers for Disease Control and Prevention (CDC) case definition of COVID-19, which tested for milder disease. The study enrolled 3,732 participants ages 12 to less than 18 years in the U.S.\nThe Moderna COVID-19 vaccine was generally well tolerated with a safety and tolerability profile generally consistent with the Phase 3 COVE study in adults. No significant safety concerns have been identified to date. The majority of adverse events were mild or moderate in severity. The most common solicited local adverse event was injection site pain. The most common solicited systemic adverse events after the second dose of mRNA-1273 were headache, fatigue, myalgia and chills. Safety data continues to accrue, and the study continues to be monitored by an independent safety monitoring committee. All participants will be monitored for 12 months after their second injection to assess long-term protection and safety. These data are subject to change based on ongoing data collection.\nAbout the Moderna COVID-19 Vaccine \nThe Moderna COVID-19 Vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the National Institutes of Health (NIH) on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of the Moderna COVID-19 Vaccine was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the U.S Food and Drug Administration granted the Moderna COVID-19 Vaccine Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of the vaccine. On July 8, the Phase 2 study completed enrolment.\nResults from the second interim analysis of the NIH-led Phase 1 study of the Moderna COVID-19 Vaccine in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine. On November 30, 2020, Moderna announced the primary efficacy analysis of the Phase 3 study of the vaccine conducted on 196 cases. On November 30, 2020, the Company also announced that it filed for Emergency Use Authorization with the U.S. FDA and a Conditional Marketing Authorization (CMA) application with the European Medicines Agency. On December 18, 2020, the U.S. FDA authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age or older. Moderna has received emergency (or other conditional, interim or provisional) authorization for use of its COVID-19 vaccine in adults from health agencies in Canada, Israel, the European Union, the United Kingdom, Switzerland, Singapore, Qatar, Taiwan, the Philippines, Thailand, Brunei, Paraguay, Japan, South Korea, Botswana and an Emergency Use Listing (EUL) from the World Health Organization (WHO).\nInitial data from Moderna’s Phase 2 study in the U.S. showed that a single 50 µg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants of concern, B.1.351 (first identified in South Africa) and P.1 (first identified in Brazil). A booster dose of mRNA-1273.351, the Company’s strain-matched booster, achieved higher neutralizing antibody titers against the B.1.351 variant of concern than a booster dose of mRNA-1273. Safety and tolerability profiles following third dose booster injections of 50 µg of mRNA-1273 or mRNA-1273.351 were generally comparable to those observed after the second dose of mRNA-1273 in the previously reported Phase 2 and Phase 3 studies. A manuscript describing these preliminary results was submitted as a preprint to medRxiv and will be submitted for peer-reviewed publication upon completion of the multivalent mRNA-1273.211 booster arm.\nAbout Moderna\nIn 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.\nModerna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 14 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182921513,"gmtCreate":1623551218032,"gmtModify":1631889801999,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"🤔🤔","listText":"🤔🤔","text":"🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/182921513","repostId":"2143788716","repostType":4,"isVote":1,"tweetType":1,"viewCount":1658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186279847,"gmtCreate":1623505781889,"gmtModify":1631889802004,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/186279847","repostId":"1147474880","repostType":4,"repost":{"id":"1147474880","kind":"news","pubTimestamp":1623470168,"share":"https://ttm.financial/m/news/1147474880?lang=&edition=full","pubTime":"2021-06-12 11:56","market":"us","language":"en","title":"Investor, Trader, Speculator: Which One Are You?","url":"https://stock-news.laohu8.com/highlight/detail?id=1147474880","media":"The Wall Street Journal","summary":"Understanding the difference between speculation and investing is essential to avoiding reckless ris","content":"<blockquote>\n Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n</blockquote>\n<p>I’ve had it.</p>\n<p>The Wall Street Journal is wrong, and has remained wrong for decades, about one of the most basic distinctions in finance. And I can’t stand it anymore.</p>\n<p>If you buy a stock purely because it’s gone up a lot, without doing any research on it whatsoever, you are not—as the Journal and its editors bizarrely insist on calling you—an “investor.” If you buy a cryptocurrency because, hey, that sounds like fun, you aren’t an investor either.</p>\n<p>Whenever you buy any financial asset becauseyou have a hunchorjust for kicks, or becausesomebody famous is hyping the heck out of itoreverybody else seems to be buying it too, you aren’t investing.</p>\n<p>You’re definitely a trader: someone who has just bought an asset. And you may bea speculator: someone who thinks other people will pay more for it than you did.</p>\n<p>Of course,some folkswho buy meme stocks likeGameStopCorp.GME5.88%<i>are</i>investors. They read the companies’ financial statements, study the health of the underlying businesses and learn who else is betting on or against the shares. Likewise, many buyers of digital coins have put in the time and effort to understand how cryptocurrency works and how it could reshape finance.</p>\n<p>An investor relies on internal sources of return: earnings, income, growth in the value of assets. A speculator counts on external sources of return: primarilywhether somebody else will pay more, regardless of fundamental value.</p>\n<p>The word investor comes from the Latin “investire,” to dress in or clothe oneself, surround or envelop. You would never wear clothes without knowing what color they are or what material they’re made of. Likewise, you can’t invest in an asset you know nothing about.</p>\n<p>Nevertheless, the Journal and its editors have long called almost everybody who buys just about anything an “investor.” On July 12, 1962, the Journal publisheda letter to the editorfrom Benjamin Graham, author of the classic books “Security Analysis” and “The Intelligent Investor.” That June, complained Graham, the Journal had run an article headlined “Many Small Investors Bet on Further Drops, Sell Odd Lots Short.”</p>\n<p>He wrote: “By what definition of ‘investment’ can one give the name ‘investors’ to small people who make bets on the stock market by selling odd lots short?” (To short an odd lot is to borrow and sell fewer than 100 shares in a wager that a stock will fall—an expensive and risky bet, then and now.)</p>\n<p>“If these people are investors,” asked Graham, “how should one define ‘speculation’ and ‘speculators’? Isn’t it possible that the currentfailure to distinguishbetweeninvestment and speculationmay do grave harm not only to individuals but to the whole financial community—as it did in the late 1920s?”</p>\n<p>Graham wasn’t a snob who thought that the markets should be the exclusive playground of the rich. He wrote “The Intelligent Investor” with the express purpose of helping less-wealthy people participate wisely in the stock market.</p>\n<p>In that book, after which this column is named, Graham said, “Outright speculation is neither illegal, immoral, nor (for most people) fattening to the pocketbook.”</p>\n<p>However, he warned, it creates three dangers: “(1) speculating when you think you are investing; (2) speculating seriously instead of as a pastime, when you lack proper knowledge and skill for it; and (3) risking more money in speculation than you can afford to lose.”</p>\n<p>Most investors speculate a bit every once in a while. Like a lottery ticket or an occasional visit to the racetrack or casino, a little is harmless fun. A lot isn’t.</p>\n<p>If you think you’re investing when you’re speculating, you’ll attribute even momentary success to skill even thoughluck is the likeliest explanation. That can lead you to take reckless risks.</p>\n<p>Take speculating too seriously, and it turns intoan obsessionandan addiction. You become incapable of accepting your losses or focusing on the future more than a few minutes ahead. Next thing you know, you’re throwing even more money onto the bonfire.</p>\n<p>I think calling traders and speculators “investors” shoves many newcomers farther down the slippery slope toward risks they shouldn’t take and losses they can’t afford. I fervently hope the Journal and its editors will finally stop using “investor” as the default term for anyone who makes a trade.</p>\n<p>“ ‘Investor’ has a long history in the English language as a catch-all term denoting people who commit capital with the expectation of a return, no matter how long or short, no matter how many or how few investing columns they read,” WSJ Financial Editor Charles Forelle said in response to my complaints. “Back at least to the mid-19th century, ‘invest’ has even been used to describe a wager on horses—an activity surely no less divorced from fundamental analysis than a purchase of dogecoin.”</p>\n<p>I hear you, Boss, but I still think you’re wrong. There’s no way the Journal would say a recreational gambler is “investing” at the racetrack just because a dictionary says we can.</p>\n<p>Calling novice speculators “investors” is one of the most powerful ways marketers fuel excessive trading.</p>\n<p>Ina recent Instagram post, a former porn star who goes by the name Lana Rhoades posed in—well, mostly in—a bikini, as she held up what appears to be Graham’s “The Intelligent Investor.” According to IMDb.com, she starred in such videos as “Tushy” and “Make Me Meow.”</p>\n<p>In her post, which was “liked” by nearly 1.8 million people, Ms. Rhoades announced that she will be promoting a cryptocurrency calledPAWGcoin.</p>\n<p>The currency’s website says the coin is meant for “those who pay homage to developed posteriors.” (PAWG, I’ve been reliably informed, stands for Phat Ass White Girl.)</p>\n<p>PAWGcoin is up roughly 900% since Ms. Rhoades began promoting it in early June, according to Poocoin.io, a website that tracks such digital currencies.</p>\n<p>Ms. Rhoades, who has tweeted “I also read the WSJ every morning,” couldn’t be reached for comment. PAWGcoin’s website encourages visitors to “invest now.”</p>\n<p>In Ms. Rhoades’s Instagram post, she is holding up an open copy of the “The Intelligent Investor,” whose cover is reversed. She appears to be reading it with her eyes closed.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investor, Trader, Speculator: Which One Are You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestor, Trader, Speculator: Which One Are You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 11:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n\nI’ve had it.\nThe Wall Street Journal is wrong, and has remained wrong for decades, about one of ...</p>\n\n<a href=\"https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147474880","content_text":"Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n\nI’ve had it.\nThe Wall Street Journal is wrong, and has remained wrong for decades, about one of the most basic distinctions in finance. And I can’t stand it anymore.\nIf you buy a stock purely because it’s gone up a lot, without doing any research on it whatsoever, you are not—as the Journal and its editors bizarrely insist on calling you—an “investor.” If you buy a cryptocurrency because, hey, that sounds like fun, you aren’t an investor either.\nWhenever you buy any financial asset becauseyou have a hunchorjust for kicks, or becausesomebody famous is hyping the heck out of itoreverybody else seems to be buying it too, you aren’t investing.\nYou’re definitely a trader: someone who has just bought an asset. And you may bea speculator: someone who thinks other people will pay more for it than you did.\nOf course,some folkswho buy meme stocks likeGameStopCorp.GME5.88%areinvestors. They read the companies’ financial statements, study the health of the underlying businesses and learn who else is betting on or against the shares. Likewise, many buyers of digital coins have put in the time and effort to understand how cryptocurrency works and how it could reshape finance.\nAn investor relies on internal sources of return: earnings, income, growth in the value of assets. A speculator counts on external sources of return: primarilywhether somebody else will pay more, regardless of fundamental value.\nThe word investor comes from the Latin “investire,” to dress in or clothe oneself, surround or envelop. You would never wear clothes without knowing what color they are or what material they’re made of. Likewise, you can’t invest in an asset you know nothing about.\nNevertheless, the Journal and its editors have long called almost everybody who buys just about anything an “investor.” On July 12, 1962, the Journal publisheda letter to the editorfrom Benjamin Graham, author of the classic books “Security Analysis” and “The Intelligent Investor.” That June, complained Graham, the Journal had run an article headlined “Many Small Investors Bet on Further Drops, Sell Odd Lots Short.”\nHe wrote: “By what definition of ‘investment’ can one give the name ‘investors’ to small people who make bets on the stock market by selling odd lots short?” (To short an odd lot is to borrow and sell fewer than 100 shares in a wager that a stock will fall—an expensive and risky bet, then and now.)\n“If these people are investors,” asked Graham, “how should one define ‘speculation’ and ‘speculators’? Isn’t it possible that the currentfailure to distinguishbetweeninvestment and speculationmay do grave harm not only to individuals but to the whole financial community—as it did in the late 1920s?”\nGraham wasn’t a snob who thought that the markets should be the exclusive playground of the rich. He wrote “The Intelligent Investor” with the express purpose of helping less-wealthy people participate wisely in the stock market.\nIn that book, after which this column is named, Graham said, “Outright speculation is neither illegal, immoral, nor (for most people) fattening to the pocketbook.”\nHowever, he warned, it creates three dangers: “(1) speculating when you think you are investing; (2) speculating seriously instead of as a pastime, when you lack proper knowledge and skill for it; and (3) risking more money in speculation than you can afford to lose.”\nMost investors speculate a bit every once in a while. Like a lottery ticket or an occasional visit to the racetrack or casino, a little is harmless fun. A lot isn’t.\nIf you think you’re investing when you’re speculating, you’ll attribute even momentary success to skill even thoughluck is the likeliest explanation. That can lead you to take reckless risks.\nTake speculating too seriously, and it turns intoan obsessionandan addiction. You become incapable of accepting your losses or focusing on the future more than a few minutes ahead. Next thing you know, you’re throwing even more money onto the bonfire.\nI think calling traders and speculators “investors” shoves many newcomers farther down the slippery slope toward risks they shouldn’t take and losses they can’t afford. I fervently hope the Journal and its editors will finally stop using “investor” as the default term for anyone who makes a trade.\n“ ‘Investor’ has a long history in the English language as a catch-all term denoting people who commit capital with the expectation of a return, no matter how long or short, no matter how many or how few investing columns they read,” WSJ Financial Editor Charles Forelle said in response to my complaints. “Back at least to the mid-19th century, ‘invest’ has even been used to describe a wager on horses—an activity surely no less divorced from fundamental analysis than a purchase of dogecoin.”\nI hear you, Boss, but I still think you’re wrong. There’s no way the Journal would say a recreational gambler is “investing” at the racetrack just because a dictionary says we can.\nCalling novice speculators “investors” is one of the most powerful ways marketers fuel excessive trading.\nIna recent Instagram post, a former porn star who goes by the name Lana Rhoades posed in—well, mostly in—a bikini, as she held up what appears to be Graham’s “The Intelligent Investor.” According to IMDb.com, she starred in such videos as “Tushy” and “Make Me Meow.”\nIn her post, which was “liked” by nearly 1.8 million people, Ms. Rhoades announced that she will be promoting a cryptocurrency calledPAWGcoin.\nThe currency’s website says the coin is meant for “those who pay homage to developed posteriors.” (PAWG, I’ve been reliably informed, stands for Phat Ass White Girl.)\nPAWGcoin is up roughly 900% since Ms. Rhoades began promoting it in early June, according to Poocoin.io, a website that tracks such digital currencies.\nMs. Rhoades, who has tweeted “I also read the WSJ every morning,” couldn’t be reached for comment. PAWGcoin’s website encourages visitors to “invest now.”\nIn Ms. Rhoades’s Instagram post, she is holding up an open copy of the “The Intelligent Investor,” whose cover is reversed. She appears to be reading it with her eyes closed.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1017,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181153722,"gmtCreate":1623380090266,"gmtModify":1631889802006,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"😱😱😱","listText":"😱😱😱","text":"😱😱😱","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181153722","repostId":"1147556990","repostType":4,"isVote":1,"tweetType":1,"viewCount":2117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183889901,"gmtCreate":1623321303303,"gmtModify":1631889802011,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"👏🏻👏🏻👏🏻","listText":"👏🏻👏🏻👏🏻","text":"👏🏻👏🏻👏🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/183889901","repostId":"1156471121","repostType":4,"repost":{"id":"1156471121","kind":"news","pubTimestamp":1623319150,"share":"https://ttm.financial/m/news/1156471121?lang=&edition=full","pubTime":"2021-06-10 17:59","market":"us","language":"en","title":"7 Movie Stocks Ready for the #AMCArmy’s Finale","url":"https://stock-news.laohu8.com/highlight/detail?id=1156471121","media":"InvestorPlace","summary":"These seven stocks are looking to rebound this summer as people return to seeing films in theaters.\n","content":"<blockquote>\n <b>These seven stocks are looking to rebound this summer as people return to seeing films in theaters.</b>\n</blockquote>\n<p>The epic rally in<b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>) stock has a lot of people fatigued. And like allmeme stock rallies, the latest one involving movie theatre chain AMC is likely to end in spectacular fashion. In one week, AMC stock rallied 157% higher, dropped 33% and then rose again by 25%.</p>\n<p>It’s been quite the rollercoaster. And what has driven the #AMCArmy of retail investors to push the share price sky high has been the fact that the world’s largest movie theatre chain was brought to theedge of bankruptcyby the Covid-19 pandemic. That, and the stock has been one of the most heavily shorted on Wall Street this year.</p>\n<p>But AMC’s problems are not unique. The entire movie industry, from production to exhibition, has beendevastated by the pandemicand many companies have struggled just like AMC.</p>\n<p>Here are seven movie stocks ready for the #AMCArmy finale.</p>\n<ul>\n <li><b>Cineplex</b>(OTCMKTS:<b><u>CPXGF</u></b>)</li>\n <li><b>Walt Disney</b>(NYSE:<b><u>DIS</u></b>)</li>\n <li><b>Lions Gate Entertainment</b>(NYSE:<b><u>LGF.A</u></b>)</li>\n <li><b>Netflix</b>(NASDAQ:<b><u>NFLX</u></b>)</li>\n <li><b>Cinemark Holdings</b>(NYSE:<b><u>CNK</u></b>)</li>\n <li><b>IMAX</b>(NYSE:<b><u>IMAX</u></b>)</li>\n <li><b>Marcus Corporation</b>(NYSE:<b><u>MCS</u></b>)</li>\n</ul>\n<p><b>Movie Stocks: Cineplex (CPXGF)</b><img src=\"https://static.tigerbbs.com/48b5992b0e1c313b454912d58ba0c08d\" tg-width=\"300\" tg-height=\"165\" referrerpolicy=\"no-referrer\">Source: Shutterstock</p>\n<p>Toronto-based Cineplex, which operates more than 165 movie theatres across Canada, has been in business since Charlie Chaplin was making silent pictures. And, like AMC and other movie theatre chains, Cineplex has had a tough go of it during the pandemic.</p>\n<p>CPXGFstock is now tradingat $13.48 a share, about half the $25.41 it was at in February 2020 before Covid-19 landed. The share price had been as low as $3.30 a share last October after the company reported its quarterly revenue plunged 95%.</p>\n<p>In addition to having its theatres shuttered for nearly a year and reopened with capacity limits, Cineplex has had to cope with a litany of other problems. First, Britain’s Cineworld Group backed out of adeal to acquire Cineplexfor $2.18 billion, a deal that would have made the merged companies the biggest operator of movie theaters in North America. Then, the company’s stock was removed fromCanada’s benchmark stock index, the<b>S&amp;P/TSX Composite Index</b>, and it was forced to sell its its head office in Toronto for $57 million CAD ($47 million) in order to raise cash to pay down debt.</p>\n<p>At last check, Cineplex was negotiating toreceive relief from its creditorsas it eagerly awaits the start of the summer movie season.</p>\n<p><b>Walt Disney (DIS)</b><img src=\"https://static.tigerbbs.com/07f8afcac0c7c6dd3846e904c09efbf7\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: Shutterstock</p>\n<p>DIS stock has had a great run over the past year, propped up by the meteoric rise of the company’s Disney+ streaming service. The Walt Disney streaming service that is home to popular film and television franchises such as Star Wars, Marvel superheroes and Pixar animation grew to103.6 million subscriberswithin 18 months of launching and kept the Mouse House afloat during the pandemic while its theme parks and cruise lines were closed.</p>\n<p>However, the shine has come off DIS stock recently over concerns that growth in the company’s streaming service will now begin to slow.</p>\n<p>However, asa diversified company, Walt Disney should perform well as its theme parks around the world reopen this summer, its cruises set sail again, and it begins developing new content for the Disney+ platform. And, the company hopes to keep its growth in streaming robust by bundling Disney+ with other content offerings that include the sports-related ESPN Plus platform and movies and TV shows offered through Hulu, both of which Disney owns. With so much diversification, it likely won’t be long before DIS stock recovers and tests new highs.</p>\n<p>DIS stock is currently at $176.81, down 13% from its 52-week high of $203.02 a share reached in March.</p>\n<p><b>Lions Gate Entertainment (LGF.A)</b><img src=\"https://static.tigerbbs.com/07033460d0624cdd53042a5aa7052595\" tg-width=\"300\" tg-height=\"199\" referrerpolicy=\"no-referrer\">Source: ©iStock.com/diego_cervo</p>\n<p>Lions Gate Entertainment is a producer of popular films and TV programs, including the<i>Hunger Games</i>,<i>John Wick</i>and<i>Saw</i>movie franchises and the Emmy Award-winning TV series<i>Mad Men</i>. The company that started life in Vancouver, British Columbia in 1997, Lions Gate is today headquartered in Santa Monica, California. Coming out of the pandemic, CEO Jon Feltheimer islooking to be acquiredby a larger studio.</p>\n<p>Investment bank<b>Loop Capital</b>has put a price target on Lions Gate of $8 billion and said any acquirer would get arich catalogueof content that also includes the<i>John Wick</i>and<i>Expendables</i>movie series, as well as TV shows such as<i>Nurse Jackie</i>,<i>Nashville</i>and<i>Weeds</i>. However, this isn’t the first time that Lions Gate hasput out a ‘for sale’ sign. The company held talks in 2018 with<b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>) and<b>Comcast</b>(NASDAQ:<b><u>CMCSA</u></b>)about a possible acquisition, though nothing ultimately came from the discussions.</p>\n<p>LGF.A stock has had a strong run, up 82% year-to-date to $20.21 a share.</p>\n<p><b>Netflix (NFLX)</b><img src=\"https://static.tigerbbs.com/55a3532d6172fc7628916587da288c86\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: Riccosta / Shutterstock.com</p>\n<p>NFLX stock has beenunder pressurelately as fears grow that the boost the company received during the pandemic is over. Netflix’s most recent earnings results did nothing to ease the fears of Wall Street. The Silicon Valley-based streaming giant reported on April 20 that it added 3.98 million subscribers in the first quarter, missing Wall Street’s estimate of 6.29 million subscribers and its own forecast of 6 million.</p>\n<p>The current quarter looks even worse with Netflix forecasting only a million new customers worldwide, less than a quarter of the 4.44 million forecast by analysts.</p>\n<p>To be fair, Netflix is largely a victim of its own success. After adding more than20 million new subscriberslast year (2020), growth was bound to level off at some point. Today, Netflix has nearly 208 million subscribers worldwide. Netflix’s subscriber growth has also been hurt by a lack of new content as TV and movie productions were halted during the pandemic.</p>\n<p>The company hopes to release a glut of new content later this year and is targeting Asia, where subscriptions grew 65% last year, for continued growth.</p>\n<p>NFLX stock has fallen 11.6% since its last quarterly results release and now trades at $485.81 a share.</p>\n<p><b>Cinemark Holdings (CNK)</b><img src=\"https://static.tigerbbs.com/9e9adffdcac440f98a123a3874db0146\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: LukeandKarla.Travel/Shutterstock.com</p>\n<p>Another major U.S. movie theatre chain besides AMC is Plano, Texas-based Cinemark Holdings. Founded in 1961, Cinemark operates movie theatres under several brands, including Cinemark, Century Theatres and Tinseltown. The company is also global with operations as far afield as Taiwan and Brazil. At its current price of $23.21 a share,CNK stockis currently at about half the $40 a share it was trading at in the summer before the global pandemic.</p>\n<p>Cinemark Holdingsrevenue got hammeredover the past year as its theatres around the world were shut. Revenues for 2020 came in at $700 million, down 80% from $3.3 billion in 2019. Losses for last year came in at record $5.25 per share.</p>\n<p>Things are beginning to improve as Covid-19 vaccination rates accelerate and with aslate of blockbuster movieson deck for the coming summer months. However, currently the majority of Cinemark Holdings theatres are operating at 50% capacity as pandemic restrictions remain in place in most jurisdictions.</p>\n<p><b>IMAX (IMAX)</b><img src=\"https://static.tigerbbs.com/32ee2bd29b44f561b3e38ce1867198f8\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: imageAllan / Shutterstock.com</p>\n<p>Canadian theatre company IMAX Corporation, which makes giant movie screens and the films that are shown on them, is another company that will be glad to see both the pandemic and the AMC stock rally end.</p>\n<p>Investment bank<b>Goldman Sachs</b>(NYSE:<b><u>GS</u></b>) recentlydowngraded IMAX stockto “sell” from “neutral” and lowered its 12-month price target on the shares to $18.60, which would be a 16% drop from the current share price of $22.04.</p>\n<p>Goldman forecasts that the U.S. box office will only recover to about three-quarters of its pre-pandemic levels, noting that movie theater attendance had been in decline before the pandemic. The bank also warned that a glut of new theatrical releases will lead new movies to cannibalize each other this summer.</p>\n<p>Despite the negative sentiment, IMAX remains hopeful. Pre-sales of the IMAX version of the upcoming<i>Fast &amp; Furious</i>film (the ninth in that series) recentlyset a record in China, one of IMAX’s biggest markets globally.</p>\n<p><b>Marcus Corp. (MCS)</b><img src=\"https://static.tigerbbs.com/8fdb7f52844c139b36c32ccbbcdfe167\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\">Source: Shutterstock</p>\n<p>Regional operator Marcus Corp. is the fourth-largest movie theatre operator in America. Its1,110 screensare primarily located in Wisconsin, Illinois, Iowa, Minnesota and Nebraska. The Milwaukee, Wisconsin-based company also owns 17 hotels and resorts in the Midwest, as well as California and Texas.</p>\n<p>The company’s first-quarter revenue came in at $50.8 million, 69% less than last year’s comparable revenue of $159.5 million.</p>\n<p>However, Marcus’ cash position remains strong, with the company reporting cash reserves of $213 million at the end ofthis year’ first quarter. Still, the pandemic has taken a toll on Marcus’ business and share price. MCS stock has traded as low as $6.84 and as high as $24.71 over the past year. The share price now stands at $22.57.</p>\n<p>In early May, Marcus reported thatnearly 90% of theatreshad reopened and that it was expanding its operating days and hours as new movies begin to be released theatrically.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Movie Stocks Ready for the #AMCArmy’s Finale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Movie Stocks Ready for the #AMCArmy’s Finale\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 17:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/7-movie-stocks-ready-for-the-amcarmys-finale/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These seven stocks are looking to rebound this summer as people return to seeing films in theaters.\n\nThe epic rally inAMC Entertainment(NYSE:AMC) stock has a lot of people fatigued. And like allmeme ...</p>\n\n<a href=\"https://investorplace.com/2021/06/7-movie-stocks-ready-for-the-amcarmys-finale/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MCS":"马库斯","CNK":"喜满客影城","NFLX":"奈飞","IMAX":"Imax Corp","DIS":"迪士尼","CPXGF":"Cineplex, Inc."},"source_url":"https://investorplace.com/2021/06/7-movie-stocks-ready-for-the-amcarmys-finale/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156471121","content_text":"These seven stocks are looking to rebound this summer as people return to seeing films in theaters.\n\nThe epic rally inAMC Entertainment(NYSE:AMC) stock has a lot of people fatigued. And like allmeme stock rallies, the latest one involving movie theatre chain AMC is likely to end in spectacular fashion. In one week, AMC stock rallied 157% higher, dropped 33% and then rose again by 25%.\nIt’s been quite the rollercoaster. And what has driven the #AMCArmy of retail investors to push the share price sky high has been the fact that the world’s largest movie theatre chain was brought to theedge of bankruptcyby the Covid-19 pandemic. That, and the stock has been one of the most heavily shorted on Wall Street this year.\nBut AMC’s problems are not unique. The entire movie industry, from production to exhibition, has beendevastated by the pandemicand many companies have struggled just like AMC.\nHere are seven movie stocks ready for the #AMCArmy finale.\n\nCineplex(OTCMKTS:CPXGF)\nWalt Disney(NYSE:DIS)\nLions Gate Entertainment(NYSE:LGF.A)\nNetflix(NASDAQ:NFLX)\nCinemark Holdings(NYSE:CNK)\nIMAX(NYSE:IMAX)\nMarcus Corporation(NYSE:MCS)\n\nMovie Stocks: Cineplex (CPXGF)Source: Shutterstock\nToronto-based Cineplex, which operates more than 165 movie theatres across Canada, has been in business since Charlie Chaplin was making silent pictures. And, like AMC and other movie theatre chains, Cineplex has had a tough go of it during the pandemic.\nCPXGFstock is now tradingat $13.48 a share, about half the $25.41 it was at in February 2020 before Covid-19 landed. The share price had been as low as $3.30 a share last October after the company reported its quarterly revenue plunged 95%.\nIn addition to having its theatres shuttered for nearly a year and reopened with capacity limits, Cineplex has had to cope with a litany of other problems. First, Britain’s Cineworld Group backed out of adeal to acquire Cineplexfor $2.18 billion, a deal that would have made the merged companies the biggest operator of movie theaters in North America. Then, the company’s stock was removed fromCanada’s benchmark stock index, theS&P/TSX Composite Index, and it was forced to sell its its head office in Toronto for $57 million CAD ($47 million) in order to raise cash to pay down debt.\nAt last check, Cineplex was negotiating toreceive relief from its creditorsas it eagerly awaits the start of the summer movie season.\nWalt Disney (DIS)Source: Shutterstock\nDIS stock has had a great run over the past year, propped up by the meteoric rise of the company’s Disney+ streaming service. The Walt Disney streaming service that is home to popular film and television franchises such as Star Wars, Marvel superheroes and Pixar animation grew to103.6 million subscriberswithin 18 months of launching and kept the Mouse House afloat during the pandemic while its theme parks and cruise lines were closed.\nHowever, the shine has come off DIS stock recently over concerns that growth in the company’s streaming service will now begin to slow.\nHowever, asa diversified company, Walt Disney should perform well as its theme parks around the world reopen this summer, its cruises set sail again, and it begins developing new content for the Disney+ platform. And, the company hopes to keep its growth in streaming robust by bundling Disney+ with other content offerings that include the sports-related ESPN Plus platform and movies and TV shows offered through Hulu, both of which Disney owns. With so much diversification, it likely won’t be long before DIS stock recovers and tests new highs.\nDIS stock is currently at $176.81, down 13% from its 52-week high of $203.02 a share reached in March.\nLions Gate Entertainment (LGF.A)Source: ©iStock.com/diego_cervo\nLions Gate Entertainment is a producer of popular films and TV programs, including theHunger Games,John WickandSawmovie franchises and the Emmy Award-winning TV seriesMad Men. The company that started life in Vancouver, British Columbia in 1997, Lions Gate is today headquartered in Santa Monica, California. Coming out of the pandemic, CEO Jon Feltheimer islooking to be acquiredby a larger studio.\nInvestment bankLoop Capitalhas put a price target on Lions Gate of $8 billion and said any acquirer would get arich catalogueof content that also includes theJohn WickandExpendablesmovie series, as well as TV shows such asNurse Jackie,NashvilleandWeeds. However, this isn’t the first time that Lions Gate hasput out a ‘for sale’ sign. The company held talks in 2018 withAmazon(NASDAQ:AMZN) andComcast(NASDAQ:CMCSA)about a possible acquisition, though nothing ultimately came from the discussions.\nLGF.A stock has had a strong run, up 82% year-to-date to $20.21 a share.\nNetflix (NFLX)Source: Riccosta / Shutterstock.com\nNFLX stock has beenunder pressurelately as fears grow that the boost the company received during the pandemic is over. Netflix’s most recent earnings results did nothing to ease the fears of Wall Street. The Silicon Valley-based streaming giant reported on April 20 that it added 3.98 million subscribers in the first quarter, missing Wall Street’s estimate of 6.29 million subscribers and its own forecast of 6 million.\nThe current quarter looks even worse with Netflix forecasting only a million new customers worldwide, less than a quarter of the 4.44 million forecast by analysts.\nTo be fair, Netflix is largely a victim of its own success. After adding more than20 million new subscriberslast year (2020), growth was bound to level off at some point. Today, Netflix has nearly 208 million subscribers worldwide. Netflix’s subscriber growth has also been hurt by a lack of new content as TV and movie productions were halted during the pandemic.\nThe company hopes to release a glut of new content later this year and is targeting Asia, where subscriptions grew 65% last year, for continued growth.\nNFLX stock has fallen 11.6% since its last quarterly results release and now trades at $485.81 a share.\nCinemark Holdings (CNK)Source: LukeandKarla.Travel/Shutterstock.com\nAnother major U.S. movie theatre chain besides AMC is Plano, Texas-based Cinemark Holdings. Founded in 1961, Cinemark operates movie theatres under several brands, including Cinemark, Century Theatres and Tinseltown. The company is also global with operations as far afield as Taiwan and Brazil. At its current price of $23.21 a share,CNK stockis currently at about half the $40 a share it was trading at in the summer before the global pandemic.\nCinemark Holdingsrevenue got hammeredover the past year as its theatres around the world were shut. Revenues for 2020 came in at $700 million, down 80% from $3.3 billion in 2019. Losses for last year came in at record $5.25 per share.\nThings are beginning to improve as Covid-19 vaccination rates accelerate and with aslate of blockbuster movieson deck for the coming summer months. However, currently the majority of Cinemark Holdings theatres are operating at 50% capacity as pandemic restrictions remain in place in most jurisdictions.\nIMAX (IMAX)Source: imageAllan / Shutterstock.com\nCanadian theatre company IMAX Corporation, which makes giant movie screens and the films that are shown on them, is another company that will be glad to see both the pandemic and the AMC stock rally end.\nInvestment bankGoldman Sachs(NYSE:GS) recentlydowngraded IMAX stockto “sell” from “neutral” and lowered its 12-month price target on the shares to $18.60, which would be a 16% drop from the current share price of $22.04.\nGoldman forecasts that the U.S. box office will only recover to about three-quarters of its pre-pandemic levels, noting that movie theater attendance had been in decline before the pandemic. The bank also warned that a glut of new theatrical releases will lead new movies to cannibalize each other this summer.\nDespite the negative sentiment, IMAX remains hopeful. Pre-sales of the IMAX version of the upcomingFast & Furiousfilm (the ninth in that series) recentlyset a record in China, one of IMAX’s biggest markets globally.\nMarcus Corp. (MCS)Source: Shutterstock\nRegional operator Marcus Corp. is the fourth-largest movie theatre operator in America. Its1,110 screensare primarily located in Wisconsin, Illinois, Iowa, Minnesota and Nebraska. The Milwaukee, Wisconsin-based company also owns 17 hotels and resorts in the Midwest, as well as California and Texas.\nThe company’s first-quarter revenue came in at $50.8 million, 69% less than last year’s comparable revenue of $159.5 million.\nHowever, Marcus’ cash position remains strong, with the company reporting cash reserves of $213 million at the end ofthis year’ first quarter. Still, the pandemic has taken a toll on Marcus’ business and share price. MCS stock has traded as low as $6.84 and as high as $24.71 over the past year. The share price now stands at $22.57.\nIn early May, Marcus reported thatnearly 90% of theatreshad reopened and that it was expanding its operating days and hours as new movies begin to be released theatrically.","news_type":1,"symbols_score_info":{"CNK":0.9,"CPXGF":0.9,"DIS":0.9,"IMAX":0.9,"LGF":0.9,"MCS":0.9,"NFLX":0.9}},"isVote":1,"tweetType":1,"viewCount":1258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117331216,"gmtCreate":1623116311735,"gmtModify":1631889802013,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"😱😱","listText":"😱😱","text":"😱😱","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/117331216","repostId":"2141259492","repostType":4,"repost":{"id":"2141259492","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623115139,"share":"https://ttm.financial/m/news/2141259492?lang=&edition=full","pubTime":"2021-06-08 09:18","market":"fut","language":"en","title":"Oil falls again amid concerns over demand rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2141259492","media":"Reuters","summary":"TOKYO, June 8 (Reuters) - Oil prices lost more ground on Tuesday as concerns about the fragile state","content":"<p>TOKYO, June 8 (Reuters) - Oil prices lost more ground on Tuesday as concerns about the fragile state of the global recovery in demand for crude and fuels were heightened by data showing China's oil imports fell in May.</p><p>Brent crude&nbsp;was down 11 cents, or 0.2%, at $71.38 a barrel by 0151 GMT, after declining 0.6% overnight. U.S. oil</p><p>was off by 13 cents, or 0.2%, at $69.10 a barrel, having dropped by 0.6% in the previous session.</p><p>\"Chinese oil imports at a five-month low ... would tend to confirm weakness in the Asia market,\" said Bob Yawger, director of energy futures at Mizhuo Securities.</p><p>China's crude imports were down 14.6% in May, from a high level a year earlier, with daily arrivals at the lowest level this year, as maintenance at refineries limited demand for oil purchases.</p><p>Crude prices have risen in recent weeks, with Brent up by nearly 40% this year and WTI gaining more than that, amid expectations of demand to return as some countries succeed in vaccinating populations against COVID-19.</p><p>Restraint on supply by the Organization of the Petroleum Exporting Countries and allies has also helped buttress prices.</p><p>But major oil importers like India have been going through waves of infections that continue to threaten the expected pickup in global demand in the second half of this year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil falls again amid concerns over demand rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil falls again amid concerns over demand rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-08 09:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, June 8 (Reuters) - Oil prices lost more ground on Tuesday as concerns about the fragile state of the global recovery in demand for crude and fuels were heightened by data showing China's oil imports fell in May.</p><p>Brent crude&nbsp;was down 11 cents, or 0.2%, at $71.38 a barrel by 0151 GMT, after declining 0.6% overnight. U.S. oil</p><p>was off by 13 cents, or 0.2%, at $69.10 a barrel, having dropped by 0.6% in the previous session.</p><p>\"Chinese oil imports at a five-month low ... would tend to confirm weakness in the Asia market,\" said Bob Yawger, director of energy futures at Mizhuo Securities.</p><p>China's crude imports were down 14.6% in May, from a high level a year earlier, with daily arrivals at the lowest level this year, as maintenance at refineries limited demand for oil purchases.</p><p>Crude prices have risen in recent weeks, with Brent up by nearly 40% this year and WTI gaining more than that, amid expectations of demand to return as some countries succeed in vaccinating populations against COVID-19.</p><p>Restraint on supply by the Organization of the Petroleum Exporting Countries and allies has also helped buttress prices.</p><p>But major oil importers like India have been going through waves of infections that continue to threaten the expected pickup in global demand in the second half of this year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UCO":"二倍做多彭博原油ETF","USO":"美国原油ETF","DWT":"三倍做空原油ETN","DDG":"ProShares做空石油与天然气ETF","SCO":"二倍做空彭博原油指数ETF","DUG":"二倍做空石油与天然气ETF(ProShares)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141259492","content_text":"TOKYO, June 8 (Reuters) - Oil prices lost more ground on Tuesday as concerns about the fragile state of the global recovery in demand for crude and fuels were heightened by data showing China's oil imports fell in May.Brent crude was down 11 cents, or 0.2%, at $71.38 a barrel by 0151 GMT, after declining 0.6% overnight. U.S. oilwas off by 13 cents, or 0.2%, at $69.10 a barrel, having dropped by 0.6% in the previous session.\"Chinese oil imports at a five-month low ... would tend to confirm weakness in the Asia market,\" said Bob Yawger, director of energy futures at Mizhuo Securities.China's crude imports were down 14.6% in May, from a high level a year earlier, with daily arrivals at the lowest level this year, as maintenance at refineries limited demand for oil purchases.Crude prices have risen in recent weeks, with Brent up by nearly 40% this year and WTI gaining more than that, amid expectations of demand to return as some countries succeed in vaccinating populations against COVID-19.Restraint on supply by the Organization of the Petroleum Exporting Countries and allies has also helped buttress prices.But major oil importers like India have been going through waves of infections that continue to threaten the expected pickup in global demand in the second half of this year.","news_type":1,"symbols_score_info":{"DDG":0.9,"DUG":0.9,"DWT":0.9,"BZmain":0.9,"CLmain":0.9,"QMmain":0.9,"SCO":0.9,"UCO":0.9,"USO":0.9}},"isVote":1,"tweetType":1,"viewCount":1198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114263626,"gmtCreate":1623075781565,"gmtModify":1631889802017,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"👍🏻👍🏻👍🏻","listText":"👍🏻👍🏻👍🏻","text":"👍🏻👍🏻👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/114263626","repostId":"1158917999","repostType":4,"isVote":1,"tweetType":1,"viewCount":1011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115627895,"gmtCreate":1622989244517,"gmtModify":1631889802025,"author":{"id":"3582101588853029","authorId":"3582101588853029","name":"yooniique","avatar":"https://static.tigerbbs.com/20d8b8e7a747237d1216fd5a0d6f3278","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582101588853029","authorIdStr":"3582101588853029"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/115627895","repostId":"1128534499","repostType":4,"isVote":1,"tweetType":1,"viewCount":1258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}